{
    "clinical_study": {
        "@rank": "20010", 
        "arm_group": [
            {
                "arm_group_label": "Acute Normovolemic Hemodilution", 
                "description": "Patients that receive acute normovolemic hemodilution prior to surgery."
            }, 
            {
                "arm_group_label": "Tranexamic Acid", 
                "description": "Patients that receive tranexamic acid during surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "This is an observational, prospective study to evaluate the role of tranexamic acid in\n      reducing blood transfusion in neonates undergoing cardiopulmonary bypass."
        }, 
        "brief_title": "The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Congenital Heart Disease", 
        "condition_browse": {
            "mesh_term": [
                "Heart Diseases", 
                "Heart Defects, Congenital"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All neonates undergoing arterial switch or aortic arch procedure utilizing\n             cardiopulmonary bypass (CPB).\n\n        Exclusion Criteria:\n\n          -  Jehovah's witness patients."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "28 Days", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients from the cardiothoracic surgery population at Nationwide Children's Hospital."
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914211", 
            "org_study_id": "IRB13-00350"
        }, 
        "intervention": [
            {
                "arm_group_label": "Tranexamic Acid", 
                "description": "100mg/kg prior to incision, 100mg/kg on CPB and 100mg/kg after reversal of heparin with protamine.", 
                "intervention_name": "Tranexamic Acid", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Acute Normovolemic Hemodilution", 
                "description": "Draw 20 mL/kg (up to 5Kg) of blood from patient and replace with washed PRBCs at 10-20mL/kg.  (If > 5Kg draw 20% of circulating blood volume without PRBC replacement)", 
                "intervention_name": "Acute Normovolemic Hemodilution", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Tranexamic Acid"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43205"
                }, 
                "name": "Nationwide Children's Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluating the body's ability to stop or decrease postoperative bleeding.", 
            "measure": "Level of postoperative hemostasis", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914211"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Nationwide Children's Hospital", 
            "investigator_full_name": "Aymen N Naguib", 
            "investigator_title": "Director of Pediatric Cardiothoracic Anesthesia", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Assessing the need for and amount of blood transfusions during the 1st 24 hours post-op.", 
            "measure": "Volume of blood transfusions", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "source": "Nationwide Children's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Aymen N Naguib", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}